rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2009-3-23
|
pubmed:abstractText |
Preoperative portal vein embolization (PVE) is performed to minimize perioperative risks of major hepatic resection for hepatocellular carcinoma (HCC), but its effects on tumor growth are ill defined. Perioperative outcome and survival after major hepatic resection for HCC, with and without PVE, were investigated.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1532-7361
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
145
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
399-405
|
pubmed:meshHeading |
pubmed-meshheading:19303988-Adult,
pubmed-meshheading:19303988-Aged,
pubmed-meshheading:19303988-Aged, 80 and over,
pubmed-meshheading:19303988-Carcinoma, Hepatocellular,
pubmed-meshheading:19303988-Disease-Free Survival,
pubmed-meshheading:19303988-Embolization, Therapeutic,
pubmed-meshheading:19303988-Female,
pubmed-meshheading:19303988-Humans,
pubmed-meshheading:19303988-Liver Neoplasms,
pubmed-meshheading:19303988-Male,
pubmed-meshheading:19303988-Middle Aged,
pubmed-meshheading:19303988-Portal Vein,
pubmed-meshheading:19303988-Retrospective Studies,
pubmed-meshheading:19303988-Treatment Outcome,
pubmed-meshheading:19303988-United States,
pubmed-meshheading:19303988-Young Adult
|
pubmed:year |
2009
|
pubmed:articleTitle |
Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival.
|
pubmed:affiliation |
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|